New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
23:38 EDTHPY, PETM, LMT, AMGN, HD, JCP, CSCOJim Cramer's "Mad Money"
Cramer said it's downright infuriating, just when the housing market was beginning to recover, autos were getting stronger, retail sales were growing and banks looked like they were finally finding their footing, Congress has been able to undo it all and send our markets sharply lower. We're now facing the first congressionally mandated bear market we've ever seen, said Cramer, all because 536 people couldn't agree. For the year, U.S. stocks are now up just half of their counterparts in Europe, and Europe is in a recession. Cramer came up with three indicators to help investors figure out whether the effects of the fiscal cliff are baked into the markets and whether its time to begin buying back in. First: "Washington on TV" indicator. Anytime the president or member of Congress gets on the air, expect the markets to go lower. Second: Lockheed Martin (LMT), the defense contractor with a 5% dividend yield. If the U.S. falls over the fiscal cliff, Lockheed will get hurt by both defense spending cuts and a rise in dividend taxes, Cramer noted, making this stock uniquely positioned to feel the blow. Third: Investors can use Cisco (CSCO), Home Depot (HD) and Petsmart (PETM) as gauges for Washington's damage. Cramer said all three of these companies posted stellar earnings, so if they can't hold onto their gains, no one can. SELL BLOCK: Cramer reminded viewers some stocks go down because they deserve to, and that's certainly the case with J.C. Penney (JCP). The company remains a value trap and is showing no signs of improving. Penney has had three disappointing quarters in a row, Cramer noted, and sales still continue to decline, dramatically so, and the company's balance sheet is weakening. Then, continuing with his "Upside Surprise Party" series of stocks to buy as the markets continue to fall on fiscal cliff worries, Cramer recommended drug maker Amgen (AMGN). The company has a huge pipeline of new drugs on the way and a 1.7% yield. Trading at just 12x earnings with a 10.5% long-term growth rate, Cramer said he's never seen Amgen trade as low as it is right now. EXECUTIVE DECISION: Cramer sat down with Robert Carr, chairman and CEO of Heartland Payment Systems (HPY), our nation's fifth-largest payment processor. Heartland's most recent quarterly results included a 5c earnings beat on better-than-expected revenue with upside guidance. Cramer continued his recommendation and said Heartland Payment Systems is a great story. NO HUDDLE OFFENSE: Cramer offered his quick "Top 5" reasons why they shouldn't be sellers in Friday's market. First: stocks are already very oversold -- there will be a better time to sell later. Second: while many stocks will be impacted by the fiscal cliff, others, like international names, will not, which is why it's prudent to buy, not sell, into weakness. Third: everything gets baked into stock prices eventually, and stocks often bottom before big events occur, not after. Fourth: the higher taxes and spending cuts of the fiscal cliff won't be the end of the world for certain sectors, like health care and those that offer consumers a bargain. And, Fifth: companies with big dividends will likely be able to raise those dividends to cover, at least partially, any higher tax rates from the fiscal cliff. Reference Link
News For LMT;CSCO;HD;PETM;JCP;AMGN;HPY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 18, 2015
13:30 EDTJCPJ.C. Penney trades lower after news of executive departures
Subscribe for More Information
09:36 EDTHDActive equity options trading on open
Subscribe for More Information
05:35 EDTCSCODeutsche Telekom and Cisco launch intercloud services on OpenStack
Deutsche Telekom (DTEGY) and Cisco (CSCO) are announcing a newly developed Intercloud-based services for small- and medium-sized businesses and enterprise customers. The two companies announced their Intercloud collaboration in September 2014. Deutsche Telekom and Cisco are currently setting up the necessary infrastructure for a redundant Intercloud node in Deutsche Telekom's high-performance data centers in Magdeburg and Biere near Berlin, Germany. Deutsche Telekom will deliver sovereign and highly secure services that meet Germany's strict data protection standards to business customers throughout the European region.
March 17, 2015
16:11 EDTAMGNAmgen to present 10 abstracts from dermatology portfolio
Subscribe for More Information
15:41 EDTJCPJ.C. Penney General Counsel Janet Dhillon leaving, Bloomberg says
Subscribe for More Information
14:41 EDTLMTLockheed Martin nearing F-16 upgrade deal with Singapore, Defense News says
Subscribe for More Information
07:18 EDTLMTSatellite & Access Intelligence to hold a exhibition
Subscribe for More Information
06:57 EDTJCPJ.C. Penney CMO leaves company, effective immediately, AdAge reports
Subscribe for More Information
March 16, 2015
10:21 EDTCSCOVicor says SynQor power converter claims held to be invalid
In a unanimous decision, the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., on March 13 issued a ruling invalidating key claims of a power converter patent asserted by SynQor Inc. against Vicor Corporation (VICR) and Cisco Systems (CSCO) in litigation currently pending in the United States District Court for the Eastern District of Texas. Reversing a decision of the United States Patent and Trademark Office, the Federal Circuit agreed with Vicor that prior art anticipated certain claims of SynQor's 7,072,190 patent and ordered the USPTO to reconsider the obviousness of the remaining claims. Commenting on the decision, Dr. Patrizio Vinciarelli, Vicor's CEO, stated, "The Federal Circuit decision turns the tables on SynQor, which resorted to attacking competitors and customers with bogus intellectual property after failing in the marketplace with its inferior bus converters. As a company founded on innovation, Vicor respects legitimate IP interests of others. However, Vicor will confront abusive IP litigation where, as here, illegitimate claims are asserted to suppress competition from superior products known not to infringe." Vicor has asserted counterclaims against SynQor. In its counterclaims, Vicor seeks damages for unfair and deceptive trade practices and tortious interference engaged in by SynQor as part of its campaign to discourage customers from using Vicor's superior products so as to monopolize the bus converter market. Vicor will hold SynQor, and its principals, accountable for damages they have intentionally caused.
08:52 EDTAMGNAmgen to hold a conference call
Conference call to provide an update from the 73rd Annual Meeting of AAD will be held on March 23 at 3 pm. Webcast Link
08:35 EDTAMGNAmgen to hold a conference call
Executive Vice President of R&D, Sean Harper, discusses Amgen's cardiovascular program, including the Repatha data currently being presented at the American College of Cardiology's Scientific Session & Expo, on a conference call to be held on March 16 at 4 pm. Webcast Link
08:23 EDTAMGNPCSK9 data continues to impress, says Leerink
Subscribe for More Information
07:32 EDTCSCOUBM Tech to hold a conference
Enterprise Connect 2015 is being held in Orlando, Florida on March 16-19.
06:57 EDTAMGNAmgen clinical data very positive, says RBC Capital
Subscribe for More Information
06:40 EDTAMGNPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
06:09 EDTCSCOStocks with implied volatility below IV index mean; CSCO QCOM
Subscribe for More Information
March 15, 2015
13:11 EDTAMGNAmgen publishes safety analysis of Repatha in New England Journal of Medicine
Subscribe for More Information
12:53 EDTAMGNAmgen announces new data from study of Repatha in combination with statins
Subscribe for More Information
March 13, 2015
06:03 EDTCSCOStocks with implied volatility below IV index mean; AMZN QCOM
Subscribe for More Information
March 12, 2015
08:20 EDTJCPImperial Capital says $3 target on J.C. Penney likely too high
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use